ClinConnect ClinConnect Logo
Search / Trial NCT02650453

Ongoing Registry of Deep Venous Reconstructions

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Jan 7, 2016

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Stent Angioplasty Endophlebectomy

ClinConnect Summary

This clinical trial, called the Ongoing Registry of Deep Venous Reconstructions, is looking at how effective certain treatments are for patients with blockage in their deep veins, specifically in areas like the femoral vein and iliac veins. The treatments being studied include a procedure known as percutaneous transluminal angioplasty (PTA), where a small balloon is used to open up the blocked vein, as well as the placement of a stent to keep the vein open. Some patients may also undergo a surgical procedure to remove blockages.

To be eligible for this trial, participants must have a blockage in one of the targeted veins, but they cannot have a life expectancy of less than one year or be unable to tolerate blood-thinning medications. This study is currently recruiting participants of all ages and genders. Those who join the trial can expect to receive one of these treatments and will be monitored throughout the process to see how well it helps improve their condition. It's an important opportunity to contribute to the understanding and improvement of treatments for venous thrombosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Venous obstruction/occlusion in the femoral vein, common femoral vein, external iliac vein, common iliac vein or inferior vena cava
  • Exclusion Criteria:
  • Intolerance to anticoagulant medication
  • A life expectancy \<1 year

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, , Netherlands

Maastricht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Cees Wittens, MD, PhD

Principal Investigator

Maastricht University Medical Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials